+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma



Occurrence of Psoriasiform Eruption During Nivolumab Therapy for Primary Oral Mucosal Melanoma



JAMA Dermatology 151(7): 797-799




(PDF emailed within 0-6 h: $19.90)

Accession: 058448683

Download citation: RISBibTeXText

PMID: 25875052

DOI: 10.1001/jamadermatol.2015.0249


Related references

Psoriasiform eruption on the face and extremities associated with nivolumab therapy. Jaad Case Reports 4(4): 373-375, 2018

Inverse Psoriasiform Eruption During Pembrolizumab Therapy for Metastatic Melanoma. JAMA Dermatology 152(5): 590-592, 2018

Exacerbation of psoriasis vulgaris during nivolumab for oral mucosal melanoma. Journal of the European Academy of Dermatology and Venereology 30(10): E89-E91, 2015

A Psoriasiform Drug Eruption Secondary to Nivolumab for Hepatocellular Carcinoma: A Case Report. Hepatology 2019, 2019

Synergistic effects of interferon-beta and nivolumab in oral mucosal melanoma. Journal of Dermatology 45(1): 87-90, 2017

Successful rechallenge with nivolumab therapy after radiotherapy in mucosal melanoma. Journal of Dermatology 2018, 2018

Primary mucosal melanoma of the oral cavity: current therapy and future directions. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 122(1): 17-27, 2017

Establishment and characterization of an oral mucosal melanoma cell line (MEMO) derived from a longstanding primary oral melanoma. American Journal of Dermatopathology 35(2): 248-251, 2013

Kaposi's varicelliform eruption in a patient with metastatic melanoma and primary cutaneous anaplastic large cell lymphoma treated with talimogene laherparepvec and nivolumab. Journal for ImmunoTherapy of Cancer 6(1): 122, 2018

Serum level of interleukin-6 is increased in nivolumab-associated psoriasiform dermatitis and tumor necrosis factor-α is a biomarker of nivolumab recativity. Journal of Dermatological Science 86(1): 71-73, 2017

Efficacy of nivolumab monotherapy against acral lentiginous melanoma and mucosal melanoma in Asian patients. British Journal of Dermatology 2018, 2018

Primary malignant melanoma of esophagus shared similar genetic characters with both cutaneous and oral mucosal melanoma. Journal of Thoracic Disease 10(Suppl 17): S2095-S2096, 2018

Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncology 44(11): 1039-1046, 2008

Mucosal Lichen Planus Mimicking Mucosal Lesions in Stevens-Johnson Syndrome after Nivolumab Therapy. Acta Dermato-Venereologica 2019, 2019

Psoriasiform skin eruption associated with sorafenib therapy. Indian Journal of Dermatology, Venereology and Leprology 77(5): 614-615, 2012